Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system

Vaccine

Volumn 31, Issue 5, 2013, Pages 784-790

  Meerak, Jomkhwan ^a,b   Wanichwecharungruang, Supason P ^a   Palaga, Tanapat ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Autophagy; Chitosan; DNA vaccine; MTOR; Mycobacterium tuberculosis

Indexed keywords

AG 85B; BACTERIAL ANTIGEN; BCG VACCINE; CHITOSAN; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; MAMMALIAN TARGET OF RAPAMYCIN; PLASMID DNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; AUTOPHAGY; BACTERIAL GENE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA IMMUNIZATION; DRUG EFFICACY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPLEEN CELL; TH1 CELL; WILD TYPE;

ACYLTRANSFERASES; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, BACTERIAL; AUTOPHAGY; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHITOSAN; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; SPLEEN; TOR SERINE-THREONINE KINASES; TUBERCULOSIS VACCINES; VACCINES, DNA;

EID: 84872610333     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.11.075     Document Type: Article

References (33)

1. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., et al. Direct gene transfer into mouse muscle in vivo. Science 1990, 247(March (4949 Pt 1)):1465-1468.
2. Johnston S.A., Qu B.X., McGuire M., Stemke-Hale K., Sykes K. Applications of, and future challenges for, genetic vaccines. Dev Biol (Basel) 2000, 104:3-8.
3. Laddy D.J., Weiner D.B. From plasmids to protection: a review of DNA vaccines against infectious diseases. Int Rev Immunol 2006, 25(May-August (3/4)):99-123.
4. Yang Z., Klionsky D.J. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 2010, 22(April (2)):124-131.
5. Mizushima N. Autophagy: process and function. Genes Dev 2007, 21(November (22)):2861-2873.
6. Levine B., Mizushima N., Virgin H.W. Autophagy in immunity and inflammation. Nature 2011, 469(January (7330)):323-335.
7. Schmid D., Pypaert M., Munz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 2007, 26(January (1)):79-92.
8. Munz C. Antigen processing for MHC class II presentation via autophagy. Front Immunol 2012, 3:9.
9. Kaufmann S.H., Gengenbacher M. Recombinant live vaccine candidates against tuberculosis. Curr Opin Biotechnol 2012, 23(December (6)):900-907.
10. Bivas-Benita M., van Meijgaarden K.E., Franken K.L., Junginger H.E., Borchard G., Ottenhoff T.H., et al. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis. Vaccine 2004, 22(April (13/14)):1609-1615.
11. Mollenkopf H.J., Dietrich G., Fensterle J., Grode L., Diehl K.D., Knapp B., et al. Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles. Vaccine 2004, 22(July (21/22)):2690-2695.
12. Yao W., Liu S., Qu X., Xiao S., Liu Y., Liu J. Enhanced immune response and protection efficacy of a DNA vaccine constructed by linkage of the Mycobacterium tuberculosis Ag85B-encoding gene with the BVP22-encoding gene. J Med Microbiol 2009, 58(April (Pt 4)):462-468.
13. Okada M., Kita Y., Nakajima T., Kanamaru N., Hashimoto S., Nagasawa T., et al. Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB. Vaccine 2007, 25(April (16)):2990-2993.
14. Okada M., Kita Y. Tuberculosis vaccine development: the development of novel (preclinical) DNA vaccine. Hum Vaccin 2012, 6(April (4)):297-308.
15. Gutierrez M.G., Master S.S., Singh S.B., Taylor G.A., Colombo M.I., Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004, 119(December (6)):753-766.
16. Vergne I., Singh S., Roberts E., Kyei G., Master S., Harris J., et al. Autophagy in immune defense against Mycobacterium tuberculosis. Autophagy 2006, 2(July-September (3)):175-178.
17. Alonso S., Pethe K., Russell D.G., Purdy G.E. Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc Natl Acad Sci USA 2007, 104(April (14)):6031-6036.
18. Jagannath C., Lindsey D.R., Dhandayuthapani S., Xu Y., Hunter R.L., Eissa N.T. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med 2009, 15(March (3)):267-276.
19. Sato T., Ishii T., Okahata Y. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 2001, 22(August (15)):2075-2080.
20. Khatri K., Goyal A.K., Gupta P.N., Mishra N., Vyas S.P. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B. Int J Pharm 2008, 354(April (1/2)):235-241.
21. Chew J.L., Wolfowicz C.B., Mao H.Q., Leong K.W., Chua K.Y. Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice. Vaccine 2003, 21(June (21/22)):2720-2729.
22. Bozkir A., Saka O.M. Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics. Drug Deliv 2004, 11(March-April (2)):107-112.
23. Mao H.Q., Roy K., Troung-Le V.L., Janes K.A., Lin K.Y., Wang Y., et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 2001, 70(February (3)):399-421.
24. Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., Deck R.R., et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 1996, 2(August (8)):893-898.
25. Deretic V., Levine B. Autophagy, immunity, and microbial adaptations. Cell Host Microbe 2009, 5(June (6)):527-549.
26. Huang J., Dibble C.C., Matsuzaki M., Manning B.D. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol 2008, 28(June (12)):4104-4115.
27. Leong K.W., Mao H.Q., Truong-Le V.L., Roy K., Walsh S.M., August J.T. DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release 1998, 53(April (1-3)):183-193.
28. Kumar M., Behera A.K., Lockey R.F., Zhang J., Bhullar G., De La Cruz C.P., et al. Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Hum Gene Ther 2002, 13(August (12)):1415-1425.
29. Lozes E., Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., et al. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine 1997, 15(June (8)):830-833.
30. Miki K., Nagata T., Tanaka T., Kim Y.H., Uchijima M., Ohara N., et al. Induction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51. Infect Immun 2004, 72(April (4)):2014-2021.
31. Zhu B., Qie Y., Wang J., Zhang Y., Wang Q., Xu Y., et al. Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis. Eur J Pharm Biopharm 2007, 66(June (3)):318-326.
32. Maglione P.J., How Chan J. B cells shape the immune response against Mycobacterium tuberculosis. Eur J Immunol 2009, 39(March (3)):676-686.
33. Winau F., Weber S., Sad S., de Diego J., Hoops S.L., Breiden B., et al. Apoptotic vesicles crossprime CD8T cells and protect against tuberculosis. Immunity 2006, 24(January (1)):105-117.